Environmental Allergies in West Highland White Terriers — Management Guide

Practical, evidence-based guide to diagnosing and managing environmental allergies (atopic dermatitis) in West Highland White Terriers, including meds, Malassezia care, and daily tips.

Quick Overview

What it is

Environmental allergies (atopic dermatitis) are an immune-mediated skin disease in which a dog's immune system overreacts to inhaled or contact allergens (pollens, molds, dust mites, dander). The result is intense itching, inflamed skin, and a high risk of secondary infections.

Who's at risk

West Highland White Terriers ("Westies") are one of the breeds predisposed to canine atopic dermatitis. Signs typically begin between 6 months and 3 years of age, although later onset is possible.

Prognosis

Atopic dermatitis is a chronic, relapsing condition. With a structured plan — control of itch, treatment of infections, skin barrier support, and long-term strategies such as allergen-specific immunotherapy — most Westies can have good quality of life. Complete cure is uncommon, but clinical control is achievable in a majority of dogs.

Pathophysiology — explained simply

Atopic dermatitis results from a combination of genetic skin barrier defects and dysregulated immune responses to environmental proteins. In affected dogs, allergens penetrate an imperfect skin barrier and trigger IgE-mediated and cell-mediated inflammatory pathways. This causes pruritus (itching) and skin inflammation, which then leads to self-trauma, thickening (lichenification), and secondary overgrowth of bacteria (Staphylococcus) and yeast (Malassezia).

Breed-specific risk factors and prevalence

• Westies are overrepresented among breeds with atopic dermatitis — many dermatology referral caseloads show high prevalence in West Highland White Terriers.
• Typical patterns for Westies: facial rubbing, ventral thorax and axillae, groin, and feet are common sites. Chronic cases often develop hyperpigmentation, alopecia, and crusting.
• Westies also commonly develop Malassezia pachydermatis overgrowth (yeast), particularly in skin folds, interdigital areas, and ears, which worsens itching and odor.

Typical signs, stages and grading

Common signs

• Intense itching (scratching, chewing, rubbing)
• Red, inflamed skin (erythema)
• Recurrent ear infections (otitis externa)
• Licking/chewing of paws (pododermatitis)
• Secondary infections: greasy, smelly coat, pustules, crusts
• Chronic changes: thickened skin, hyperpigmentation, hair loss

• Acute: erythema, broken skin, severe pruritus
• Chronic: lichenification, hyperpigmentation, secondary infections

• Mild: intermittent pruritus, minimal lesions
• Moderate: daily pruritus, localized lesions, occasional infection
• Severe: constant pruritus, widespread lesions, recurrent infections, reduced quality of life

Diagnostic approach

Goal: confirm allergic disease, rule out look-alike causes (fleas, food allergy, parasites, endocrine disease), and identify secondary infections.

Steps

Imaging and labs

Routine bloodwork is not diagnostic for atopic dermatitis but may be used to screen for other disease or before long-term immunosuppressive therapy. Skin biopsy is sometimes used for atypical or treatment-resistant cases.

Treatment options

Management is multimodal: control pruritus, treat infections, restore skin barrier, and long-term strategies.

Medical therapy

• Apoquel (oclacitinib): oral Janus kinase (JAK) inhibitor. Dose concept: 0.4–0.6 mg/kg PO twice daily for up to 14 days, then once daily. Onset: rapid (often within 24 hours). Advantages: fast itch control. Caveats: not recommended for dogs <12 months or with serious infections or known neoplasia; possible side effects include GI signs and increased susceptibility to infection. Monitor regularly if long-term use.

• Cytopoint (lokivetmab): injectable anti-IL-31 monoclonal antibody. Dose concept: single subcutaneous injection, labeled dose per product (commonly ~1–2 mg/kg). Onset: within 24–48 hours; duration commonly 4–8 weeks (can be longer in some dogs). Advantage: minimal systemic immunosuppression, suitable for young dogs and those where chronic systemic immunosuppression is a concern.

• Systemic glucocorticoids: prednisone/prednisolone. Dose concept: short course (e.g., 0.5–1 mg/kg/day) tapered to lowest effective dose. Advantages: rapid, cheap. Disadvantages: many systemic side effects with long-term use—polyuria, polydipsia, increased appetite, risk of iatrogenic Cushing's.

• Cyclosporine (Atopica, generic ciclosporin): immunomodulator. Dose concept: commonly 5 mg/kg PO once daily for 4–8 weeks, then tapered as clinical response allows. Onset: weeks. Side effects: GI upset, gingival hyperplasia; monitor for infections.

• Antihistamines: variable efficacy (e.g., cetirizine, hydroxyzine). May help some dogs as adjuncts and have very low risk.

• Malassezia dermatitis: diagnosed by cytology. Topical therapy first-line: chlorhexidine 2–4% + miconazole shampoo/cleaner used 2–3 times weekly for several weeks; leave-on antifungal creams or wipes (miconazole/ketoconazole) for local areas. Systemic antifungals (itraconazole 5–10 mg/kg PO once daily for 2–4 weeks, or ketoconazole at older regimens) for severe or refractory cases. Monitor liver values if prolonged systemic azole therapy is used.

• Bacterial pyoderma: topical antiseptics (chlorhexidine washes) for superficial cases; systemic antibiotics guided by culture and sensitivity for deep or recurrent infections. Avoid empiric long-term antibiotics.

• Subcutaneous or sublingual immunotherapy tailored to an individual dog’s allergen profile can reduce clinical signs over months to years.
• Success rates: improvement reported in ~60–70% of dogs, with complete remission in a smaller proportion (20–40%); full effect may take 6–12 months.
• Requires commitment and ongoing monitoring.

• Medicated shampoos: 2–3 times weekly in flare ups (chlorhexidine +/- miconazole). Leave-on conditioners and ceramide-containing products help restore barrier function.
• Essential fatty acids: omega-3/omega-6 supplements (EPA/DHA) as adjuncts to improve skin health; benefits take weeks to months.
• Emollients and moisturizing sprays/creams: help with dry, flaky skin and reduce transepidermal water loss.

• Rarely required for environmental allergy. Surgery is limited to treating secondary problems (e.g., severe ear canal disease requiring aural surgery) but not a treatment for atopy itself.

• Some owners use acupuncture, photobiomodulation (laser), or herbal/topical supplements; evidence is limited but these may provide adjunctive benefit in individual dogs.

Long-term management and monitoring

• Regular re-evaluation: every 3–6 months initially, then as needed.
• Monitor for secondary infections: train to check ears, paws, and folds weekly; use cytology promptly when signs recur.
• Record triggers: seasonal patterns, environmental exposures, and response to treatments.
• Minimize long-term systemic steroid use; prefer targeted therapies (Cytopoint, oclacitinib, cyclosporine) and ASIT where appropriate.
• Vaccination and parasite control: maintain routine care; some immunomodulators require consideration when vaccinating or treating infections.

Prognosis and quality of life

With appropriate multimodal therapy most Westies can lead comfortable lives. Dogs with severe, poorly controlled itch or recurrent deep infections have a poorer quality of life and require specialist input. Many dogs on regular Cytopoint or oclacitinib plus topical management show marked improvement in pruritus and activity within days to weeks.

Living with Environmental Allergies — practical daily tips

• Bathing: regular medicated baths (chlorhexidine/miconazole) while flares are active; emollient shampoos in maintenance.
• Paws: wipe and inspect paws after walks; consider booties in high-pollen seasons.
• Home environment: reduce indoor dust mite exposure (wash bedding weekly in hot water, use allergen-proof covers, reduce carpeting where possible).
• Flea control: strict year‑round flea prevention — even a single flea bite can cause severe itch in allergic dogs.
• Diet: maintain a high-quality diet; if food allergy not ruled out, work through an elimination trial before labeling atopy as the sole cause.
• Grooming: regular gentle grooming to remove allergens and skin scales; avoid harsh products.

When to see your vet urgently

Seek immediate veterinary care if your Westie has:

• Sudden worsening of pustular or painful skin lesions
• Signs of systemic illness (fever, lethargy, inappetence)
• Severe ear pain, head tilt, or neurological signs
• Rapidly spreading skin infection or deep pyoderma
• Difficulty breathing or facial swelling (possible anaphylaxis)

Practical notes on drug choices and monitoring

• Apoquel (oclacitinib): rapid control; avoid in young puppies (<12 months) and dogs with serious infections or cancer. Monitor for infections and discuss long-term safety with your vet.
• Cytopoint (lokivetmab): excellent option for many Westies because of rapid, specific action with minimal systemic immunosuppression. Repeat injections every 4–8 weeks as needed.
• Cyclosporine: useful for steroid-sparing, but expect slower onset; monitor for GI signs and infections.
• Malassezia treatment: topical therapy is first-line; systemic azoles are effective but require liver monitoring with prolonged use.

Key evidence and guidelines

This guidance follows published specialty recommendations for the diagnosis and management of canine atopic dermatitis (ACVIM Consensus Statement) and peer-reviewed studies on oclacitinib and lokivetmab demonstrating rapid reductions in pruritus when used appropriately.

This guide is for educational purposes. Always consult your veterinarian for diagnosis and treatment.

Frequently Asked Questions